{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:02:33Z","timestamp":1794888153442,"version":"4.9.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiated thyroid carcinoma (DTC) is a common endocrine malignancy, and cervical lymph node metastasis (LNM) represents the predominant pattern of disease recurrence. For patients who develop persistent or recurrent cervical lesions following total thyroidectomy and radioactive iodine (131I) therapy, conventional reoperation or additional 131I therapy often provides limited efficacy and may carry increased procedural risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study included 238 patients with persistent or recurrent cervical LNM after prior thyroidectomy and 131I therapy who were treated between January 2020 and January 2024. Among them, 118 patients received 125I seed implantation with thyroid-stimulating hormone (TSH) suppression. After 1:1 propensity score matching (PSM), 110 patients were included in each group for analysis. Short-term efficacy, thyroglobulin (Tg), radiologic changes, dosimetric consistency, survival outcomes, and adverse events were compared. Dynamic changes in Tg levels and the short-axis diameter of LNM were analyzed using a linear mixed-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After PSM, the partial response rates at 6 and 12 months were significantly higher in the 125I+TSH group. 125I+TSH therapy was an independent predictor of partial response. Patients in the 125I+TSH group exhibited a faster decline in Tg levels, with an average reduction of approximately 14.5% per month and a reduction in the short-axis diameter of LNM of 4.8% per month, corresponding to biochemical and morphological half-lives of 4.4 and 14.2 months, respectively. The overall incidence of adverse events was low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>125I seed implantation combined with TSH suppression therapy accelerates Tg decline and lesion regression and demonstrates good safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1747769","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:46:41Z","timestamp":1778215601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of 125I seed implantation combined with thyroid-stimulating hormone suppression therapy in cervical lymph node metastases of differentiated thyroid carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yi","family":"Ruan","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people\u2019s hospital of Changde city)","place":["Changde, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people\u2019s hospital of Changde city)","place":["Changde, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people\u2019s hospital of Changde city)","place":["Changde, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiological Physics Technology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University (Hunan Cancer Hospital)","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people\u2019s hospital of Changde city)","place":["Changde, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people\u2019s hospital of Changde city)","place":["Changde, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17419-1","article-title":"Landmark studies in differentiated thyroid cancer","volume":"32","author":"Fisher","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.surge.2024.07.004","article-title":"Distant lymph node metastasis in differentiated thyroid cancer: a population-based cohort study","volume":"23","author":"Ding","year":"2025","journal-title":"Surgeon"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/s0140-6736(25)00629-4","article-title":"Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial","volume":"406","author":"Mallick","year":"2025","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-025-02263-4","article-title":"Reprogramming of thyroid cancer metabolism: from mechanism to therapeutic strategy","volume":"24","author":"Wan","year":"2025","journal-title":"Mol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07187-1","article-title":"(131)I SPECT\/CT provides prognostic information in patients with differentiated thyroid cancer","volume":"52","author":"Heinrich","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae617","article-title":"Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/biomedicines13020255","article-title":"Radiofrequency ablation for locoregional structural incomplete response in differentiated thyroid cancer: initial experience in Greece","volume":"13","author":"Simeakis","year":"2025","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-017-4660-2","article-title":"Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer","volume":"274","author":"Kim","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.07.1633","article-title":"Long-term results of external beam radiation therapy with or without concurrent chemotherapy in differentiated thyroid cancer","volume":"35","author":"Choi","year":"2025","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1327766","article-title":"The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma","volume":"15","author":"Wan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1325987","article-title":"(125)I seed implantation for lymph node metastasis from radioactive iodine-refractory differentiated thyroid carcinoma: a study on short-term efficacy and dosimetry","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8130422","article-title":"Analysis of the influencing factors of tumor volume, body immunity, and poor prognosis after (125)I particle therapy for differentiated thyroid cancer","volume":"2023","author":"Tan","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B14","article-title":"Clinical efficacy of iodine-125 ((125)I) seed implantation in patients with iodine-refractory differentiated thyroid cancer","volume":"13","author":"Su","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2023.110868","article-title":"Clinical value of (125)I radioactive seed implantation in the treatment of lymph node metastasis of (131)I refractory differentiated thyroid cancer","volume":"199","author":"Wenwen","year":"2023","journal-title":"Appl Radiat Isot"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.3390\/jcm14145000","article-title":"Recombinant human TSH versus thyroid hormone withdrawal: the role in the preparation for RAI therapy in differentiated thyroid cancer: a comprehensive evidence-based review","volume":"14","author":"Daraghma","year":"2025","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202513243","article-title":"TSH ligand-based CAR-T cell effectively eradicates TSHR-positive thyroid cancer with favorable safety profile","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651088","article-title":"Personalised immunotherapy strategies informed by single cell profiling in thyroid cancer: a mini review","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.70028","article-title":"Synergizing photodynamic therapy and ethanol ablation: light-activatable sustained-exposure ethanol injection technology for enhanced tumor ablation","volume":"10","author":"Ma","year":"2025","journal-title":"Bioeng Transl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/jco-25-00274","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: 10-year outcomes of the FLAME trial","volume":"43","author":"Menne Guricova","year":"2025","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102393","article-title":"Carfilzomib promotes iodine-125 seed radiation-induced apoptosis, paraptosis, and ferroptosis in esophageal squamous cell carcinoma by aggravating endoplasmic reticulum stress","volume":"57","author":"Wang","year":"2025","journal-title":"Transl Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114231","article-title":"Bilayer nanofiber-coated stent integrating internal radiation and spatiotemporal IL-12 release promotes antitumor immune response","volume":"387","author":"Qin","year":"2025","journal-title":"J Control Release"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-025-01214-w","article-title":"In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta\/gamma-emitting radionuclides","volume":"15","author":"Salas-Ramirez","year":"2025","journal-title":"EJNMMI Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0173","article-title":"Regulation of thyroid hormone levels by hypothalamic thyrotropin-releasing hormone neurons","volume":"33","author":"Costa","year":"2023","journal-title":"Thyroid"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.remnie.2024.500026","article-title":"Update on radiation protection of the thyroid gland","volume":"43","author":"Negre","year":"2024","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2025.104623","article-title":"Dosimetric impact of iodinated contrast agent on planning CT for volumetric-modulated radiotherapy of head and neck cancer","volume":"29","author":"Leyrat","year":"2025","journal-title":"Cancer Radiother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-024-00478-2","article-title":"The importance of patient reported outcomes in oncology clinical trials and clinical practice to inform regulatory and healthcare decision-making","volume":"24","author":"Bellino","year":"2024","journal-title":"Drugs R D"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1747769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:46:48Z","timestamp":1778215608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1747769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1747769"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1747769","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2026.1747769.s001","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1747769"}}